Clinuvel Pharmaceuticals
CUV.AX
#7968
Rank
NZ$0.63 B
Marketcap
NZ$12.58
Share price
3.73%
Change (1 day)
20.21%
Change (1 year)

Earnings for Clinuvel Pharmaceuticals (CUV.AX)

Earnings in 2025: NZ$59.05 Million

According to Clinuvel Pharmaceuticals's latest financial reports the company's current earnings are NZ$62.5 Million. In 2025 the company made an earning of NZ$59.05 Million, an increase over its 2024 earnings that were of NZ$58.9 Million. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Clinuvel Pharmaceuticals from 2000 to 2025

Annual earnings

Year Earnings Change
2025NZ$59.05 M0.26%
2024NZ$58.9 M11.35%
2023NZ$52.89 M28.31%
2022NZ$41.22 M22.8%
2021NZ$33.57 M112.63%
2020NZ$15.78 M-28.73%
2019NZ$22.15 M32.79%
2018NZ$16.68 M75.41%
2017NZ$9.51 M-332.52%
2016-NZ$4.1 Million-70.68%
2015-NZ$13.96 Million53.78%
2014-NZ$9.08 Million-16.1%
2013-NZ$10.82 Million-37.92%
2012-NZ$17.43 Million-18.19%
2011-NZ$21.3 Million25.31%
2010-NZ$17 Million-21.53%
2009-NZ$21.66 Million-11.27%
2008-NZ$24.42 Million80.4%
2007-NZ$13.54 Million-2.46%
2006-NZ$13.88 Million-5.35%
2005-NZ$14.66 Million60.55%
2004-NZ$9.13 Million97.37%
2003-NZ$4.63 Million50.62%
2002-NZ$3.08 Million121.22%
2001-NZ$1.39 Million254.48%
2000-NZ$0.4 Million